Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2025 Earnings Call Transcript August 4, 2025
Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $0.15, expectations were $-0.51.
Operator: Good afternoon all, and thank you for joining us for the Castle Biosciences’ Q2 2025 Earnings Call. As a reminder, this call is being recorded. We will begin today’s call with opening remarks and introductions, followed by a question-and-answer session. I’d now like to turn the call over to...
